US$ 20.03
glp-1 houston Finding Weight Loss Treatments in GLP-1 Weight Loss Plan -
Description
Renal effects of dpp-4 inhibitor sitagliptin or glp-1 receptor agonist liraglutide in overweight patients with type 2 diabetes: a 12-week, randomized, double-blind, placebo-controlled trial

Gastroenterology 133 (5), 16371648

Novo Nordisk vs
GLP-1 drugs have become a game-changer in treating obesity and type 2 diabetes, forecast to reach a $100 billion market value by 2030
